Our aim

• We are looking for novel targets and concepts in the treatment of dermatological diseases
  • Targets can be proteins or nucleic acids whose function can be modulated by a small molecule or biological therapy; which have a scientific rationale in a disease of interest, but which have not been necessarily validated in that indication
  • Concepts can be mechanisms, pathways, or cell players not previously linked to a disease of interest

Our partners

• Universities
• Research Centers
• Start-ups and Biotechs
• Pharmaceutical companies

world-wide with an interest in pharmaceutical R&D

Your benefits

• Research grants from €25000 to €100000
  • Funding to be granted at Almirall’s discretion
  • Final amount will depend on the specific proposal and it may be provided in one or several installment
• Intellectual property rights with the applicant
  • You will retain ownership of any intellectual property you may bring or develop
• Additional scientific support will be provided on an ad-hoc basis
  • Mentorship by Almirall experts to advance the initial proposal to meet project criteria
  • Technology platforms to assist in your target validation
  • Pharmacological tools
  • Advise for intellectual property matters
• A specific contact person to help you with any questions available at any time
• Further collaboration envisioned beyond the initial project

Collaboration process

• Proposal submission
  • The first step is for you to create an account on the AlmirallShare Innovation platform, which is a secure site to store and manage your proposals
  • The call will be opened from October 8^th, 2018 to February 28^th, 2019
  • Please include an outline of your idea (max. 300 words) and a detailed description of your proposal attaching documents/publications that support it
  • All the initial information provided under the proposal should be non-confidential
• Proposal evaluation and selection
  • A team of Almirall scientific experts will evaluate your proposal
  • The evaluation process will be completed 8-10 weeks after the submission deadline
  • After the evaluation period, you will receive Almirall’s decision on your proposal
• Start of collaboration
  • If your proposal has been selected, the Shared Innovation team will help you with the collaboration agreement
  • An Almirall scientist will be assigned to collaborate with you on project definition as well as project follow-up